Thu01292015

Last update 07:21:43 AM EST

mHealth Tools Significantly Improve Adherence Among HIV Patients

mHealth Tools Significantly Improve Adherence Among HIV Patients

New mobile health (mHealth) tools have demonstra...

Scientists Use Modified RNA for Telomere Extension

Scientists Use Modified RNA for Telomere Extension

Scientists discovered a new procedure that can q...

FDA Grants Fast Track Designation to BioCryst's HAE Candidate

FDA Grants Fast Track Designation to BioCryst's HAE Candidate

Durham-based BioCryst Pharmaceuticals recently a...

HHS Announces Goals to Shift Medicare Payments from Volume to Value

HHS Announces Goals to Shift Medicare Payments from Volume to Value

The US Department of Health and Human Services (...

FDA Grants Fast Track Designation to BioCryst's HAE Candidate

FDA Grants Fast Track Designation to BioCryst's HAE Candidate

Durham-based BioCryst Pharmaceuticals recently announced that US health regula...

PARI's Electronic Nebulizer Receives FDA Approval for Cystic Fibrosis Patients

PARI's Electronic Nebulizer Receives FDA Approval for Cystic Fibrosis Patients

The US Food and Drug Administration (FDA) has approved the first electronic ne...

Scientists Use Modified RNA for Telomere Extension

Scientists Use Modified RNA for Telomere Extension

Scientists discovered a new procedure that can quickly and efficiently increas...

Shire Gains as FDA Approves NPS Pharma's Endocrine Disorder Drug

Shire Gains as FDA Approves NPS Pharma's Endocrine Disorder Drug

On Friday, the US Food and Drug Administration (FDA) approved NPS Pharmaceutic...

European Health Regulators to Review AstraZeneca's Investigational Gout Drug

European Health Regulators to Review AstraZeneca's Investigational Gout Drug

The European Medicines Agency (EMA) has accepted AstraZeneca’s marketing autho...

mHealth Tools Significantly Improve Adherence Among HIV Patients

mHealth Tools Significantly Improve Adherence Among HIV Patients

New mobile health (mHealth) tools have demonstrated effectiveness in aiding HI...

Merck Returns Rights of Mid-Stage Cancer Candidate to Symphogen

Merck Returns Rights of Mid-Stage Cancer Candidate to Symphogen

Privately-held biopharmaceutical company Symphogen announced that it has regai...

Bill Reintroduced to Improve Patient Access in Medically Underserved Areas

Bill Reintroduced to Improve Patient Access in Medically Underserved Areas

Today, a bipartisan legislation was introduced in the US House of Representati...

HHS Announces Goals to Shift Medicare Payments from Volume to Value

HHS Announces Goals to Shift Medicare Payments from Volume to Value

The US Department of Health and Human Services (HHS) announced that under a ne...

FDA Approves New Glucose Monitoring App for Data-Sharing Among Diabetic Patients and Caregivers

FDA Approves New Glucose Monitoring App for Data-Sharing Among Diabetic Patients and Caregivers

The US Food and Drug Administration (FDA) allowed marketing of the first set o...

Intrexon to Buy Remaining Stake in Exemplar Genetics

Intrexon to Buy Remaining Stake in Exemplar Genetics

Today, Intrexon Corporation announced that it has launched a tender offer to a...

Array BioPharma Gains Rights to Novartis' Cancer Candidate

Array BioPharma Gains Rights to Novartis' Cancer Candidate

Array BioPharma has struck a deal with Novartis Pharma AG for rights to an inv...

Syncona and UCL Business Form Cancer Immunotherapy Company Autolus

Syncona and UCL Business Form Cancer Immunotherapy Company Autolus

Backed with roughly $45.5 million, Investment company Syncona and UCL Business...

Sarah Cannon and Syapse Collaborate for Precision Oncology Clinical Services

Sarah Cannon and Syapse Collaborate for Precision Oncology Clinical Services

In a move to personalize medicine, Sarah Cannon, the global cancer enterprise ...

Study Finds Drug Combo Suppresses Tumor Growth in Late-Stage Prostate Cancer

Study Finds Drug Combo Suppresses Tumor Growth in Late-Stage Prostate Cancer

Low doses of a popular diabetes drug in combination with a gene inhibitor know...

Amgen Submits Applications for Approval of its Multiple Myeloma Drug Kyprolis in the US and Europe

Amgen Submits Applications for Approval of its Multiple Myeloma Drug Kyprolis in the US and Europe

Amgen and its subsidiary Onyx Pharmaceuticals, Inc. recently announced that it...

Insys' Ovarian Cancer Treatment Receives Orphan Drug Designation from the FDA

Insys' Ovarian Cancer Treatment Receives Orphan Drug Designation from the FDA

The US Food and Drug Administration (FDA) granted Orphan Drug designation for ...

Study Finds Gene Linked to Treatment-Resistance in Patients with Testicular Cancer

Study Finds Gene Linked to Treatment-Resistance in Patients with Testicular Cancer

Scientists have uncovered several new genetic mutations that could drive testi...

Kite Pharma and Tel Aviv Sourasky Medical Center Expand Agreement for Novel CAR T Cell Therapy Products

Kite Pharma and Tel Aviv Sourasky Medical Center Expand Agreement for Novel CAR T Cell Therapy Products

Today, Kite Pharma, Inc. announced that it has expanded its immuno-oncology pa...